Examples of using Develop a hypersensitivity reaction in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
About 5 in every 100 patients, who are treated with abacavir, develop a hypersensitivity reaction.
Anyone taking Ziagen could develop a hypersensitivity reaction to abacavir, which could be life threatening if they continue to take Ziagen.
In clinical studies approximately 5% of subjects receiving abacavir develop a hypersensitivity reaction.
Anyone taking Trizivir could develop a hypersensitivity reaction to abacavir, which could be life threatening if they continue to take Trizivir.
In clinical studies approximately 5% of subjects receiving abacavir(which is also the active substance of Ziagen) develop a hypersensitivity reaction.
About 5 in every 100 patients, who are treated with Ziagen, develop a hypersensitivity reaction to the active ingredient abacavir.
Patients taking Ziagen may develop a hypersensitivity reaction(serious allergic reaction) which can be life-threatening if treatment with Ziagen is continued.
Since Trizivir contains abacavir(which is also the active substance of Ziagen)some patients taking Trizivir may develop a hypersensitivity reaction(serious allergic reaction) which can be life-threatening if you continue to take Trizivir.
Some people who take abacavir may develop a hypersensitivity reaction(a serious allergic reaction), which can be life-threatening if they continue to take abacavir containing products.
Since Kivexa contains abacavir some patients taking Kivexa may develop a hypersensitivity reaction(serious allergic reaction) which can be life-threatening if you continue to take Kivexa.
In clinical studies approximately 5% of subjects receiving abacavir develop a hypersensitivity reaction; some of these cases were life-threatening and resulted in a fatal outcome despite taking precautions.
Since Ziagen contains abacavir some patients taking Ziagen may develop a hypersensitivity reaction(serious allergic reaction) which can be life-threatening if treatment with Ziagen is continued.
Since Kivexa contains abacavir some patients taking Kivexa may develop a hypersensitivity reaction(serious allergic reaction) which can be life-threatening if treatment with Kivexa is continued.
Since Trizivir contains abacavir(Ziagen)some patients taking Trizivir may develop a hypersensitivity reaction(serious allergic reaction) which can be life-threatening if treatment with Trizivir is continued.
About 3 to 4 in every 100 patients treated with abacavir in a clinical trial who did not have the HLA- B*5701 gene developed a hypersensitivity reaction.
If a patient develops a hypersensitivity reaction during the TORISEL infusion, despite the premedication, the infusion must be stopped and the patient observed for at least 30 to 60 minutes depending on the severity of the reaction. .
If however, you suspect you are developing a hypersensitivity reaction contact your doctor immediately who will advise you whether you should stop taking Ziagen.
If however, you suspect you are developing a hypersensitivity reaction(see above) contact your doctor immediately who will advise you whether you should stop taking Trizivir.
In clinical studies, approximately 5% of subjects receiving abacavir developed a hypersensitivity reaction; some of these were life-threatening and resulted in fatal outcome despite taking precautions.
In one case of overdose the patient inadvertently received 7.6 mg of eribulin(approximately 4times the planned dose) and subsequently developed a hypersensitivity reaction(Grade 3) on Day 3 and neutropenia(Grade 3) on Day 7.
Patients who develop this hypersensitivity reaction must discontinue Trizivir and must never be rechallenged with Trizivir, or any other medicinal product containing abacavir i. e.
Patients who develop this hypersensitivity reaction must discontinue Kivexa and must never be rechallenged with Kivexa, or any other medicinal product containing abacavir Ziagen or Trizivir.
Discontinue CELSENTRI and other suspect agents immediately if signs or symptoms of severe skin or hypersensitivity reactions develop.
There is accumulating evidence that a subgroup of patients is at an increased risk of developing hypersensitivity reactions.
Almost all patients developing hypersensitivity reactions will have fever and/or rash(usually maculopapular or urticarial) as part of the syndrome, however reactions have occurred without rash or fever.